Biotricity, Inc.
BTCY
$0.52
-$0.0099-1.87%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.78% | 2.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.78% | 2.03% | |||
| Cost of Revenue | 5.87% | -3.68% | |||
| Gross Profit | 12.39% | 4.06% | |||
| SG&A Expenses | 5.91% | -24.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.98% | -17.23% | |||
| Operating Income | 45.08% | 72.45% | |||
| Income Before Tax | 21.30% | 57.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.30% | 57.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.30% | 57.73% | |||
| EBIT | 45.08% | 72.45% | |||
| EBITDA | 45.30% | 72.55% | |||
| EPS Basic | 25.99% | 85.01% | |||
| Normalized Basic EPS | 27.71% | 70.40% | |||
| EPS Diluted | 25.99% | 85.01% | |||
| Normalized Diluted EPS | 27.71% | 70.40% | |||
| Average Basic Shares Outstanding | 7.73% | 58.75% | |||
| Average Diluted Shares Outstanding | 7.73% | 58.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.23% | -0.20% | |||
